Skip to main content
. 2021 Feb 2;11:618485. doi: 10.3389/fonc.2021.618485

Figure 2.

Figure 2

Risk of progression after various treatments for recurrence in all and subgroups of patients determined by a Cox regression model: (A) in all patients (p=0.029); (B) in patients with a history of pelvic radiotherapy (p=0.255); (C) in patients with recurrence only within the pelvic cavity (p=0.005); (D) in patients with recurrence only within the pelvic cavity and with a history of pelvic radiotherapy (p=0.270); (E) in patients with recurrence only beyond the pelvic cavity (p=0.028); (F) in patients with recurrence both within and beyond the pelvic cavity (p=0.460); (G) in patients with primary surgeries (p=0.056); (H) in patients without primary surgeries (p=0.285).